In 2014, public health advocates in Colombia asked the government to issue a compulsory license on imatinib, an expensive leukemia drug marketed there by Novartis at a price almost twice the Colombian per capita income.
The Colombian Minister of Health, Alejandro Gaviria, indicated in April 2016 that he would declare a compulsory license to be in the public interest, one of the steps in issuing a compulsory license in Colombia.
LAW No. 1733/87 (FEK 171 A’ of 22.09.1987)
"Technology transfer, inventions, and technological innovation" as amended
by Art. 18, of Law No. 1739/1987 (FEK 201, A’ of 20.11.1987)
PART ONE -INDUSTRIAL PROPERTY ORGANISATION (OBI)
. . .
PART TWO PATENTS
This is work in progress, and is part of a larger project on timelines. This particular timeline is unfinished, and may contain errors.
Timeline of privileged regarding the commercialization and use of knowledge
On July 14, 2009, at the WIPO Conference on Intellectual Property and Public Policy Issues, Michael Kock (Global Head IP Seeds and Biotechnology at Syngenta International AG) underscored that today’s global challenges can only dealt with in an efficient manner by creating innovation networks which included the reward of substantial amounts of money to solve technical challenges and problems.
I’m not sure who has been sharing this on the list, but the very worst country in the negotiations, among the 190+ members of the WHO, is, without a doubt, Sweden. Sweden has been making it very difficult for Europe to take reasonable positions in the negotiations, and Sweden is consistently taking the most extreme positions in the negotiations among the European countries, and competing with Mexico for the most anti-consumer views in the room.
The IGWG Negotiations are coming to the end, and although it is not clear what the package the negotiators will deliver is, enough of the process has been seen to rate the performances of some of the actors.